Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.

Arthritis care & research - 1 May 2021

Fairley Jessica L, Hansen Dylan, Proudman Susanna, Sahhar Joanne, Ngian Gene-Siew, Walker Jenny, Strickland Gemma, Wilson Michelle, Morrisroe Kathleen, Ferdowsi Nava, Major Gabor, Roddy Janet, Stevens Wendy, Nikpour Mandana

Abstract excerpt

OBJECTIVE: To describe the clinical characteristics and outcomes of systemic sclerosis-mixed connective tissue disease (SSc-MCTD) and SSc overlap syndrome. METHODS: We included patients from the Australian Scleroderma Cohort Study who met American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for SSc. Three mutually exclusive groups were created: SSc-MCTD, SSc overlap, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Disease Progression

Share to Immunosuppressive Agents

Share to Risk Assessment

Share to Scleroderma, Systemic

Share to Syndrome

Source

Identifiers

PMID: 32058672
DOI: 10.1002/acr.24167

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.PMID 32058672Read ↗

Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.Semantic proximity Read ↗

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.Semantic proximity Read ↗

Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.Semantic proximity Read ↗

Epidemiology of systemic sclerosis.Semantic proximity Read ↗

Mortality in systemic sclerosis-a single centre study from the UK.Semantic proximity Read ↗

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.Semantic proximity Read ↗

The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.Semantic proximity Read ↗

Juvenile and adult-onset scleroderma: Different clinical phenotypes.Semantic proximity Read ↗

The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.Semantic proximity Read ↗

Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.Semantic proximity Read ↗

Racial and ethnic associations with interstitial lung disease and healthcare utilization in patients with systemic sclerosisSemantic proximity Read ↗

Scleroderma overlap syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.